Equities

Oryzon Genomics SA

Oryzon Genomics SA

Actions
  • Price (EUR)1.72
  • Today's Change0.008 / 0.47%
  • Shares traded13.83k
  • 1 Year change-22.61%
  • Beta0.3476
Data delayed at least 15 minutes, as of Mar 28 2024 16:35 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • ORY:MCE price moved over -1.14% to 1.74
  • ORY:MCE price rises above 15-day moving average to 1.75 at 10:00 BST
  • ORY:MCE price rises above 15-day moving average to 1.74 at 09:00 BST
  • ORY:MCE price rises above 15-day moving average to 1.75 at 09:05 BST
  • ORY:MCE price falls below 15-day moving average to 1.72 at 09:41 BST

Key statistics

On Thursday, Oryzon Genomics SA (ORY:MCE) closed at 1.72, 10.70% above the 52 week low of 1.55 set on Mar 07, 2024.
52-week range
Today
1.55Mar 07 20242.43Apr 03 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open1.73
High1.75
Low1.71
Bid1.71
Offer1.77
Previous close1.71
Average volume38.62k
Shares outstanding62.03m
Free float52.07m
P/E (TTM)--
Market cap106.07m EUR
EPS (TTM)-0.0533
EUR
Data delayed at least 15 minutes, as of Mar 28 2024 16:35 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.